Pages that link to "Q48946191"

The following pages link to Fragile X mice: reduced long-term potentiation and N-Methyl-D-Aspartate receptor-mediated neurotransmission in dentate gyrus (Q48946191):

Displaying 39 items.

• GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. (Q24625065) (← links)
• A new look at an old drug: neuroprotective effects and therapeutic potentials of lithium salts (Q26741164) (← links)
• Synaptic Wnt/GSK3β Signaling Hub in Autism (Q26765504) (← links)
• The FMRP regulon: from targets to disease convergence (Q27014002) (← links)
• Targeted pharmacological treatment of autism spectrum disorders: fragile X and Rett syndromes (Q27023257) (← links)
• Hippocampal Transcriptome Profile of Persistent Memory Rescue in a Mouse Model of THRA1 Mutation-Mediated Resistance to Thyroid Hormone. (Q27303040) (← links)
• From FMRP function to potential therapies for fragile X syndrome (Q30410502) (← links)
• Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia? (Q30447994) (← links)
• Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction (Q30586961) (← links)
• A resting EEG study of neocortical hyperexcitability and altered functional connectivity in fragile X syndrome (Q30841903) (← links)
• Delineating the Common Biological Pathways Perturbed by ASD's Genetic Etiology: Lessons from Network-Based Studies (Q33624758) (← links)
• Fragile X targeted pharmacotherapy: lessons learned and future directions (Q33785983) (← links)
• The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome (Q34277587) (← links)
• Fragile X syndrome: an update on developing treatment modalities (Q34292108) (← links)
• Increasing our understanding of human cognition through the study of Fragile X Syndrome (Q34435526) (← links)
• Increased long-term potentiation at medial-perforant path-dentate granule cell synapses induced by selective inhibition of histone deacetylase 3 requires Fragile X mental retardation protein (Q34563831) (← links)
• Behavioral and synaptic circuit features in a zebrafish model of fragile X syndrome (Q34638909) (← links)
• Environmental enrichment reveals effects of genotype on hippocampal spine morphologies in the mouse model of Fragile X Syndrome. (Q35003579) (← links)
• Functional and structural deficits at accumbens synapses in a mouse model of Fragile X. (Q35218838) (← links)
• Synaptic NMDA receptor-mediated currents in anterior piriform cortex are reduced in the adult fragile X mouse (Q36179820) (← links)
• Aberrant dendritic excitability: a common pathophysiology in CNS disorders affecting memory? (Q36393590) (← links)
• Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics. (Q36498006) (← links)
• Glycogen synthase kinase-3 inhibitors reverse deficits in long-term potentiation and cognition in fragile X mice (Q37417156) (← links)
• The role of ionotropic glutamate receptors in childhood neurodevelopmental disorders: autism spectrum disorders and fragile x syndrome. (Q37559828) (← links)
• Longitudinal in vivo developmental changes of metabolites in the hippocampus of Fmr1 knockout mice (Q37642816) (← links)
• Aβ oligomer-induced synapse degeneration in Alzheimer's disease (Q37871455) (← links)
• Pharmacotherapy for Fragile X Syndrome: Progress to Date. (Q38726962) (← links)
• Altered Connectivity and Synapse Maturation of the Hippocampal Mossy Fiber Pathway in a Mouse Model of the Fragile X Syndrome. (Q40376074) (← links)
• Age-Dependent Long-Term Potentiation Deficits in the Prefrontal Cortex of the Fmr1 Knockout Mouse Model of Fragile X Syndrome (Q41270458) (← links)
• FMRP Mediates Chronic Ethanol-Induced Changes in NMDA, Kv4.2, and KChIP3 Expression in the Hippocampus (Q41902713) (← links)
• Treating a novel plasticity defect rescues episodic memory in Fragile X model mice (Q46229249) (← links)
• Loss of FMRP Impaired Hippocampal Long-Term Plasticity and Spatial Learning in Rats (Q47105240) (← links)
• Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome. (Q47255421) (← links)
• Normal CA1 Place Fields but Discoordinated Network Discharge in a Fmr1-Null Mouse Model of Fragile X Syndrome (Q47553088) (← links)
• Rescue of NMDAR-dependent synaptic plasticity in Fmr1 knock-out mice (Q47723002) (← links)
• Tweaking the social network (Q48545366) (← links)
• Fragile-X Syndrome Is Associated With NMDA Receptor Hypofunction and Reduced Dendritic Complexity in Mature Dentate Granule Cells (Q61814303) (← links)
• Synaptic GluN2A-Containing NMDA Receptors: From Physiology to Pathological Synaptic Plasticity (Q89896340) (← links)
• Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Hippocampal Synaptic Transmission and Plasticity: New Therapeutic Suggestions for Fragile X Syndrome (Q91893762) (← links)